Health and Family Services Public Health Laboratory Services
Actual FY 2024Actual FY 2025Revised FY 2026Recommended FY 2027Recommended FY 2028
SOURCE OF FUNDS
General Fund
Regular Appropriation5,779,2006,251,0006,201,4006,141,4006,231,000
State Salary and Compensation Allocation121,800
Other3,100,000(300,000)
Total General Fund9,001,0005,951,0006,201,4006,141,4006,231,000
Restricted Funds
Balance Forward1,272,6773,224,995423,000282,000141,000
Current Receipts7,403,9598,929,7399,879,80011,879,80012,629,800
Non-Revenue Receipts(3,291,723)(1,700,000)(1,700,000)(1,700,000)
Total Restricted Funds8,676,6368,863,0118,602,80010,461,80011,070,800
Federal Fund
Balance Forward(3,841)
Current Receipts100,99858,952110,000110,000110,000
Total Federal Fund97,15758,952110,000110,000110,000
TOTAL SOURCE OF FUNDS17,774,79314,872,96314,914,20016,713,20017,411,800
EXPENDITURES BY CLASS
Personnel Costs8,179,9528,293,0948,891,0008,834,7008,924,300
Operating Expenses6,362,3456,143,3575,727,8007,724,2008,474,400
Grants Loans Benefits7,50113,50013,40013,30013,100
TOTAL EXPENDITURES14,549,79814,449,95214,632,20016,572,20017,411,800
EXPENDITURES BY FUND SOURCE
General Fund9,001,0005,951,0006,201,4006,141,4006,231,000
Restricted Funds5,451,6418,440,0008,320,80010,320,80011,070,800
Federal Fund97,15758,952110,000110,000110,000
TOTAL EXPENDITURES14,549,79814,449,95214,632,20016,572,20017,411,800
The Division of Laboratory Services (DLS) performs sophisticated state of the art chemical, biological, and molecular laboratory testing. In partnership with federal, state, and local entities, testing performed at the state public health laboratory supports critical activities like disease investigation, control, prevention and surveillance; food safety; and environmental health and protection. Leveraging expertise and resources, DLS serves as a reference center for hospitals and local health departments across the Commonwealth.
DLS detects and identifies a wide variety of microorganisms (bacterial and viral) and toxic chemical substances that pose a threat to public health. These include infectious agents related to food-borne disease outbreaks, seasonal influenza, and high-risk and high mortality diseases like antibiotic resistant tuberculosis, hospital-associated pneumonia, and sepsis. This requires the use of technology such as Next-Generation Sequencing (NGS) to look for relatedness between organisms that are identified from human or food sources. DLS also tests for environmental contaminants like pesticides in fruits or vegetables sold at farmers markets and bacterial contamination in commercial dairy products. When DLS identifies hospital-associated infections or dangerous, emerging infectious pathogens such as the Zika or Ebola virus, methods for their detection are rapidly deployed. Timely and precise detection of these biological agents is essential for effectively limiting spread and harm to the public.